UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$321M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$214M |
| 3 |
Zimmer Biomet
ZBH
|
+$207M |
| 4 |
Ecolab
ECL
|
+$192M |
| 5 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$189M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$251M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$225M |
| 3 |
AGN
Allergan Inc
AGN
|
+$221M |
| 4 |
Apple
AAPL
|
+$201M |
| 5 |
American Express
AXP
|
+$180M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.57% |
| 2 | Technology | 14.63% |
| 3 | Financials | 14.16% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VAL
1001
DELISTED
Valspar
VAL
| $4.98M | ﹤0.01% |
59,246
+26
| +0% | +$2.24K |
|
|
GEVA
1002
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $4.97M | ﹤0.01% |
51,000
+3,400
| +7% | +$360K |
|
1003
Transocean
RIG
$5.82B
| $4.95M | ﹤0.01% |
337,346
-51,209
| -13% | -$830K |
|
1004
Antero Resources
AR
$10.7B
| $4.92M | ﹤0.01% |
139,426
+5,107
| +4% | +$192K |
|
|
GTLS
1005
DELISTED
Chart Industries
GTLS
| $4.87M | ﹤0.01% |
138,707
-1,547
| -1% | -$49.7K |
|
|
WPG
1006
DELISTED
Washington Prime Group Inc.
WPG
| $4.85M | ﹤0.01% |
32,394
-494
| -2% | -$76.6K |
|
1007
Pebblebrook Hotel Trust
PEB
$2.05B
| $4.84M | ﹤0.01% |
103,966
+2,900
| +3% | +$138K |
|
|
BDN
1008
Brandywine Realty Trust
BDN
$554M
| $4.83M | ﹤0.01% |
302,486
+3,600
| +1% | +$57.9K |
|
1009
Gartner
IT
$11.7B
| $4.81M | ﹤0.01% |
57,373
+414
| +0.7% | +$34.2K |
|
|
WWAV
1010
DELISTED
The WhiteWave Foods Company
WWAV
| $4.79M | ﹤0.01% |
108,032
+405
| +0.4% | +$15.5K |
|
1011
Lamar Advertising Co
LAMR
$16.3B
| $4.78M | ﹤0.01% |
80,676
+30,857
| +62% | +$1.76M |
|
1012
Cadence Design Systems
CDNS
$93.4B
| $4.78M | ﹤0.01% |
258,980
+877
| +0.3% | +$16K |
|
1013
G-III Apparel Group
GIII
$1.5B
| $4.78M | ﹤0.01% |
84,800
-104,200
| -55% | -$5.37M |
|
1014
Idexx Laboratories
IDXX
$46.2B
| $4.75M | ﹤0.01% |
61,486
+162
| +0.3% | +$12.6K |
|
1015
Keysight
KEYS
$58.3B
| $4.71M | ﹤0.01% |
126,772
-6,177
| -5% | -$223K |
|
1016
Pilgrim's Pride
PPC
$6.54B
| $4.7M | ﹤0.01% |
208,190
+113,800
| +121% | +$3.23M |
|
1017
ON Semiconductor
ON
$19.3B
| $4.7M | ﹤0.01% |
387,719
-35,318
| -8% | -$405K |
|
1018
Nordson
NDSN
$17.3B
| $4.68M | ﹤0.01% |
59,702
+8,715
| +17% | +$660K |
|
1019
Alaska Air
ALK
$5.58B
| $4.68M | ﹤0.01% |
70,665
-4,085
| -5% | -$265K |
|
|
GRA
1020
DELISTED
W.R. Grace & Co.
GRA
| $4.65M | ﹤0.01% |
46,991
+47
| +0.1% | +$4.48K |
|
1021
Amphastar Pharmaceuticals
AMPH
$916M
| $4.64M | ﹤0.01% |
+310,417
| New | +$4.15M |
|
|
SPR
1022
DELISTED
Spirit AeroSystems
SPR
| $4.64M | ﹤0.01% |
88,873
+3,752
| +4% | +$179K |
|
|
DNY
1023
DELISTED
DONNELLEY R R & SONS CO
DNY
| $4.62M | ﹤0.01% |
240,707
+14,551
| +6% | +$279K |
|
|
HDP
1024
DELISTED
Hortonworks, Inc.
HDP
| $4.58M | ﹤0.01% |
192,300
-3,200
| -2% | -$74.3K |
|
1025
Myriad Genetics
MYGN
$312M
| $4.55M | ﹤0.01% |
128,500
+25,100
| +24% | +$898K |
|
Similar funds
UBS AM's Q1 2015 Portfolio in Review
As of Q1 2015, UBS AM held 2,695 positions worth $104B, down 1.3% from $105B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM withdrew a net $4.3B in Q1 2015, closing 72 positions and reducing 841 holdings. Its most notable exit was Allergan Inc, an estimated $221M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, UBS AM opened a new position in Qorvo worth $36M.
- UBS AM's largest Q1 2015 buy was Qorvo: 451,878 shares worth $36M.
- UBS AM added most to Allergan plc in Q1 2015, an estimated $321M increase.
- UBS AM's biggest Q1 2015 reduction was Walgreens Boots Alliance, cutting an estimated $251M.
- UBS AM fully exited Allergan Inc in Q1 2015, selling an estimated $221M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q1 2015.
- UBS AM opened 84 new positions and closed 72 in Q1 2015.
- UBS AM's portfolio value fell 1.3% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q1 2015, filed 4 May 2015.